Abstract:Jieyang Yu, 1, 2 Yanan Zhang, 1 Lijia Cai, 1 Qingqing Sun, 1 Wanru Li, 1 Junfang Zhou, 1 Jianmin Liang, 2 Zan Wang 1 1 Sleep Centre, Department of Neurology, The First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China; 2 Department of Pediatric Neurology, The First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China Correspondence: Jianmin Liang, Department of Pediatric Neurology, The First Hospital of Jilin University, Changchun, Jilin Province, 130021, People's Republic of China, Email Zan Wang, Sleep Centre, Department of Neurology, The First Hospital of Jilin University, Changchun, Jilin Province, 130021, People's Republic of China, Email ; Purpose: This study aimed to evaluate nocturnal sleep structure and anxiety, depression, and fatigue in patients with narcolepsy type 1 (NT1). Methods: Thirty NT1 patients and thirty-five healthy controls were enrolled and evaluated using the Epworth sleepiness scale (ESS), Generalized Anxiety Disorder-7, Patient Health Questionnaire-9, Fatigue Severity Scale (FSS), polysomnography, multiple sleep latency test, and brain function state monitoring. Statistical analyses were performed using SPSS Statistics for Windows, version 23.0. Benjamini-Hochberg correction was performed to control the false discovery rate. Results: Apart from typical clinical manifestations, patients with NT1 are prone to comorbidities such as nocturnal sleep disorders, anxiety, depression, and fatigue. Compared with the control group, patients with NT1 exhibited abnormal sleep structure, including increased total sleep time ( P adj =0.007), decreased sleep efficiency ( P adj =0.002), shortening of sleep onset latency ( P adj < 0.001), elevated wake after sleep onset ( P adj =0.002), increased N1% ( P adj =0.006), and reduced N2%, N3%, and REM% ( P adj =0.007, P adj < 0.001, P adj =0.013). Thirty-seven percent of patients had moderate to severe obstructive sleep apnea-hypopnea syndrome. And sixty percent of patients were complicated with REM sleep without atonia. Patients with NT1 displayed increased anxiety propensity ( P adj < 0.001), and increased brain fatigue ( P adj =0.020) in brain function state monitoring. FSS scores were positively correlated with brain fatigue ( P adj < 0.001) and mean sleep latency was inversely correlated with FSS scores and brain fatigue ( P adj =0.013, P adj =0.029). Additionally, ESS scores and brain fatigue decreased after 3 months of therapy ( P =0.012, P =0.030). Conclusion: NT1 patients had abnormal nocturnal sleep structures, who showed increased anxiety, depression, and fatigue. Excessive daytime sleepiness and fatigue improved after 3 months of treatment with methylphenidate hydrochloride prolonged-release tablets in combination with venlafaxine. Keywords: narcolepsy, sleep structure, excessive daytime sleepiness, anxiety, depression, fatigue Narcolepsy is a rare lifelong sleep disorder characterized by excessive daytime sleepiness (EDS), cataplexy, sleep hallucinations, and sleep paralysis. The prevalence of narcolepsy is estimated to be between 0.00023% and 0.05% in various nations worldwide, with a higher prevalence observed in males. 1–4 It can occur at any age, with two peaks at ages 15 and 35. 1,4,5 Early onset narcolepsy, with an onset age before 15 years, accounts for 86% of all cases. 6 EDS is frequently the initial symptom in younger individuals, whereas cataplexy is more common in individuals over 60 years of age. 7 In addition, patients with narcolepsy have disrupted sleep structure and are prone to comorbidities with other sleep disorders. 8 Based on the presence of cataplexy or low or absent hypocretin-1 (Hcrt-1) levels in cerebrospinal fluid (CSF), the International Classification of Sleep Disorders, Third Edition (ICSD-3) classifies narcolepsy into Narcolepsy Type 1 (NT1) and Narcolepsy Type 2. Selective loss of hypocretin (Hcrt) neurons in the lateral hypothalamus is the characteristic pathological change in NT1. 9 Current evidence favors NT1 is an autoimmune condition mediated by interactions between CD4+ T cells and CD8+ T cells in genetically susceptible individuals carrying HLA-DQB1* 06:02 or HLA-DQB1* 03:01 alleles, which affects Hcrt neurons and interferes with sleep-wakefulness neural circuits. 2,10,11 A study of 9312 narcolepsy patients conducted by Ruoff et -Abstract Truncated-

Immune Reconstitution Inflammatory Syndrome Due to HIV Treatment as a Potential Trigger: A Case Report with Late-Onset Narcolepsy

Case report: narcolepsy type 1 in an adolescent with HIV infection-coincidence or potential trigger?

Nuclear Factor of Activated T Cells and Cytokines Gene Expression of the T Cells in AIDS Patients with Immune Reconstitution Inflammatory Syndrome During Highly Active Antiretroviral Therapy

Infection, vaccination and narcolepsy type 1: Evidence and potential molecular mechanisms

Connecting the dots: An updated review of the role of autoimmunity in narcolepsy and emerging immunotherapeutic approaches

Recent insights into the pathophysiology of narcolepsy type 1

Narcolepsy and pediatric acute-onset neuropsychiatric syndrome: A case report that suggests a putative link between the two disorders

The Changed Nocturnal Sleep Structure and Higher Anxiety, Depression, and Fatigue in Patients with Narcolepsy Type 1

Increased incidence of narcolepsy following the 2009 H1N1 pandemic

Association between cytokines and symptoms of depression and anxiety in patients with type 1 narcolepsy

Newly diagnosed type 1 diabetes mellitus in a human immunodeficiency virus-infected patient with antiretroviral therapy-induced immune reconstitution inflammatory syndrome: a case report

CNS immune reconstitution inflammatory syndrome

Case Report: Orbital Myositis and Myasthenia Gravis as Symptoms of Immune Reconstitution Inflammatory Syndrome in a Patient With Human Immunodeficiency Virus Infection

Neuropsychiatric Adverse Events Following Antiretroviral Therapy in People Living with HIV: A Real-World Study of Dynamic Trends and Risk Factors in Hangzhou, China.

Increased neutrophil to lymphocyte ratio as a possible marker to detect neuroinflammation in patients with narcolepsy type 1

Anti-streptococcal Antibodies in Chinese Patients with Type-1 Narcolepsy

Identifying risk factors of immune reconstitution inflammatory syndrome in AIDS patients receiving highly active anti-retroviral therapy

Anti-IgLON5 disease with severe central sleep apnea-hypopnea syndrome: A case report

Narcolepsy risk loci are enriched in immune cells and suggest autoimmune modulation of the T cell receptor repertoire

Corticosteroid‐responsive narcolepsy type II after COVID‐19: A relevant differential diagnosis of post‐COVID syndrome (a case report)

Distinct inflammation-related proteins associated with T cell immune recovery during chronic HIV-1 infection